DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Exelixis (NASDAQ: EXEL)



company name or ticker

What to Expect from Exelixis (EXEL) This Earnings Season? (revised) - Analyst Blog

Can the Rally in Exelixis (EXEL) Shares Continue? - Tale of the Tape

What to Expect from Exelixis (EXEL) This Earnings Season? - Analyst Blog

Exelixis: A Buyout Target In The Making

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceu

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceuticals and Exelixis - Press Releases

Exelixis (EXEL) Stock Falls on Upsized Secondary Offering

Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog

3 Biotech Stocks That Could Double Before 2016

Here is a look at three small-cap biotech stocks with the potential to double within the next six months.

Pre-Market Most Active for Jul 24, 2015 : EXEL, T, AMZN, BIIB, ITEK, FB, STM, QQQ, NOK, UN, ALU, CI

Pre-Market Most Active for Jul 24, 2015 : EXEL, T, AMZN, BIIB, ITEK, FB, STM, QQQ, NOK, UN, ALU, CI

Exelixis Prices 25M Share Offering @$5.40/Share

See More Articles...